Literature DB >> 16632346

Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.

Barry L Pizer1, Claire L Weston, Kathryn J Robinson, David W Ellison, James Ironside, Frank Saran, Linda S Lashford, Diana Tait, Helen Lucraft, David A Walker, Clifford C Bailey, Roger E Taylor.   

Abstract

The SIOP PNET 3 study was designed to determine whether 10 weeks of moderately intensive chemotherapy given after surgery and before radiotherapy (RT) would improve the outcome for patients with primitive neuroectodermal tumours (PNETs) compared with RT alone. Patients with a histological diagnosis of supratentorial PNET (StPNET) and no radiological evidence of metastatic disease were initially eligible for randomisation to either chemotherapy followed by craniospinal RT 35 Gy in 21 fractions with a boost of 20 Gy in 12 fractions to the primary site, or RT alone. In respect of the increasing recognition that StPNET were high-risk tumours, randomisation for this group closed in November 1999. This analysis includes both randomised and non-randomised patients with StPNET entered into the study database. Sixty-eight patients aged 2.9-16.6 years (median 6.5 years) were included in the analysis (chemotherapy+RT: 44, RT alone: 24). Fifty-four patients (79%) had a non-pineal and 14 (21%) a pineal site. At a median follow-up of 7.4 years, for all patients overall survival (OS) at 3 and 5 years was 54.4% and 48.3%, respectively. Event-free survival (EFS) at 3 and 5 years was 50.0% and 47.0%, respectively. There was no statistically significant difference in OS or EFS according to treatment received. OS (P=0.05) and EFS (P=0.03) were significantly better for patients with pineal primary sites. EFS for pineal tumours were 92.9% at 3 years and 71.4% at 5 years and for non-pineal primaries 40.7% at 3 years and 40.7% at 5 years. This study confirmed the relatively good survival for non-metastatic pineal PNETs but poor survival of non-pineal StPNETs. There was no evidence that pre-radiation chemotherapy improved outlook. Future treatment programs should be directed at the particular natural history of these tumours, to further define prognostic factors and to explore further biological characteristics.

Entities:  

Mesh:

Year:  2006        PMID: 16632346     DOI: 10.1016/j.ejca.2006.01.039

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  34 in total

1.  DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis.

Authors:  André O von Bueren; Joachim Gerss; Christian Hagel; Haoyang Cai; Marc Remke; Martin Hasselblatt; Burt G Feuerstein; Sarah Pernet; Olivier Delattre; Andrey Korshunov; Stefan Rutkowski; Stefan M Pfister; Michael Baudis
Journal:  J Neurooncol       Date:  2012-07-07       Impact factor: 4.130

Review 2.  Pediatric brain tumors: current treatment strategies and future therapeutic approaches.

Authors:  Sabine Mueller; Susan Chang
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Treatment outcome and patterns of failure in patients of pinealoblastoma: review of literature and clinical experience from a regional cancer centre in north India.

Authors:  Ahitagni Biswas; Supriya Mallick; Suvendu Purkait; Ajeet Gandhi; Chitra Sarkar; Manmohan Singh; Pramod Kumar Julka; Goura Kishor Rath
Journal:  Childs Nerv Syst       Date:  2015-06-04       Impact factor: 1.475

4.  MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.

Authors:  A Jaju; E I Hwang; M Kool; D Capper; L Chavez; S Brabetz; C Billups; Y Li; M Fouladi; R J Packer; S M Pfister; J M Olson; L A Heier
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-10       Impact factor: 3.825

5.  Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor.

Authors:  Rachael A Lester; Lindsay C Brown; Laurence J Eckel; Robert T Foote; Amulya A NageswaraRao; Jan C Buckner; Ian F Parney; Nicholas M Wetjen; Nadia N Laack
Journal:  J Neurooncol       Date:  2014-08-13       Impact factor: 4.130

6.  Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.

Authors:  Martin Mynarek; Barry Pizer; Christelle Dufour; Dannis van Vuurden; Miklos Garami; Maura Massimino; Jason Fangusaro; Tom Davidson; Maria Joao Gil-da-Costa; Jaroslav Sterba; Martin Benesch; Nicolas Gerber; B Ole Juhnke; Robert Kwiecien; Torsten Pietsch; Marcel Kool; Steve Clifford; David W Ellison; Felice Giangaspero; Pieter Wesseling; Floyd Gilles; Nicholas Gottardo; Jonathan L Finlay; Stefan Rutkowski; Katja von Hoff
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 7.  Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research.

Authors:  Ian F Pollack
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  Primary pineal tumors: outcome and prognostic factors--a study from the Rare Cancer Network (RCN).

Authors:  Salvador Villà; Robert C Miller; Marco Krengli; Huda Abusaris; Brigitta G Baumert; Stephanie Servagi-Vernat; Sefik Igdem; Anna Lucas; Susanna Boluda; René O Mirimanoff
Journal:  Clin Transl Oncol       Date:  2012-08-23       Impact factor: 3.405

9.  A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.

Authors:  Murali Chintagumpala; Tim Hassall; Shawna Palmer; David Ashley; Dana Wallace; Kimberly Kasow; Thomas E Merchant; Matthew J Krasin; Robert Dauser; Frederick Boop; Robert Krance; Shiao Woo; Robyn Cheuk; Ching Lau; Richard Gilbertson; Amar Gajjar
Journal:  Neuro Oncol       Date:  2008-09-16       Impact factor: 12.300

10.  An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).

Authors:  H A Rogers; S Miller; J Lowe; M-A Brundler; B Coyle; R G Grundy
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.